VirnetX Holding Corp Files 10-K/A Amendment for Fiscal Year Ended December 31, 2023
Ticker: VHC · Form: 10-K/A · Filed: Apr 18, 2024 · CIK: 1082324
| Field | Detail |
|---|---|
| Company | Virnetx Holding Corp (VHC) |
| Form Type | 10-K/A |
| Filed Date | Apr 18, 2024 |
| Risk Level | low |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K/A, Amendment, VirnetX Holding Corp, SEC Filing, Fiscal Year 2023
TL;DR
<b>VirnetX Holding Corp filed an amendment to its 2023 annual report on April 18, 2024.</b>
AI Summary
VirnetX Holding Corp (VHC) filed a Amended Annual Report (10-K/A) with the SEC on April 18, 2024. VirnetX Holding Corp filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2023. The company's principal executive offices are located at 308 Dorla Court, Suite 206, Zephyr Cove, Nevada 89448. VirnetX Holding Corp's common stock trades on the NYSE Securities exchange under the ticker symbol VHC. The filing indicates the company is not a well-known seasoned issuer and is a non-accelerated filer. The amendment was filed on April 18, 2024.
Why It Matters
For investors and stakeholders tracking VirnetX Holding Corp, this filing contains several important signals. This 10-K/A filing provides updated information for the fiscal year 2023, which is crucial for investors to assess the company's current financial health and operational status. As a non-accelerated filer, this amendment may contain specific disclosures relevant to smaller reporting companies, offering insights into their reporting practices and compliance.
Risk Assessment
Risk Level: low — VirnetX Holding Corp shows low risk based on this filing. The filing is an amendment to a previous report, suggesting potential corrections or additions rather than new material events, thus posing a low immediate risk.
Analyst Insight
Investors should review the specific changes and additions made in this 10-K/A filing to understand any updated information regarding VirnetX Holding Corp's financial performance and disclosures.
Key Numbers
- 2023-12-31 — Fiscal Year End (The report covers the fiscal year ended December 31, 2023.)
- 2024-04-18 — Filing Date (The 10-K/A amendment was filed on this date.)
- 001-33852 — Commission File Number (The SEC file number for the registrant.)
- 77-0390628 — IRS Employer Identification No. (The company's IRS EIN.)
Key Players & Entities
- VirnetX Holding Corp (company) — Registrant name
- VHC (company) — Trading Symbol
- NYSE Securities (company) — Exchange
- 2023-12-31 (date) — Fiscal year end
- 2024-04-18 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Zephyr Cove, Nevada (location) — Principal executive offices
- 775 - 548-1785 (phone) — Registrant's telephone number
FAQ
When did VirnetX Holding Corp file this 10-K/A?
VirnetX Holding Corp filed this Amended Annual Report (10-K/A) with the SEC on April 18, 2024.
What is a 10-K/A filing?
A 10-K/A is a amendment to a previously filed annual report, correcting or updating financial statements or disclosures. This particular 10-K/A was filed by VirnetX Holding Corp (VHC).
Where can I read the original 10-K/A filing from VirnetX Holding Corp?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by VirnetX Holding Corp.
What are the key takeaways from VirnetX Holding Corp's 10-K/A?
VirnetX Holding Corp filed this 10-K/A on April 18, 2024. Key takeaways: VirnetX Holding Corp filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2023.. The company's principal executive offices are located at 308 Dorla Court, Suite 206, Zephyr Cove, Nevada 89448.. VirnetX Holding Corp's common stock trades on the NYSE Securities exchange under the ticker symbol VHC..
Is VirnetX Holding Corp a risky investment based on this filing?
Based on this 10-K/A, VirnetX Holding Corp presents a relatively low-risk profile. The filing is an amendment to a previous report, suggesting potential corrections or additions rather than new material events, thus posing a low immediate risk.
What should investors do after reading VirnetX Holding Corp's 10-K/A?
Investors should review the specific changes and additions made in this 10-K/A filing to understand any updated information regarding VirnetX Holding Corp's financial performance and disclosures. The overall sentiment from this filing is neutral.
How does VirnetX Holding Corp compare to its industry peers?
VirnetX Holding Corp operates in the patent licensing and technology sector, focusing on intellectual property related to secure communication networks.
Are there regulatory concerns for VirnetX Holding Corp?
The filing is made under the Securities Exchange Act of 1934, requiring public companies to submit regular financial and operational disclosures to the SEC.
Industry Context
VirnetX Holding Corp operates in the patent licensing and technology sector, focusing on intellectual property related to secure communication networks.
Regulatory Implications
The filing is made under the Securities Exchange Act of 1934, requiring public companies to submit regular financial and operational disclosures to the SEC.
What Investors Should Do
- Review the specific amendments made in the 10-K/A filing for any material changes to previously reported information.
- Analyze the company's disclosures regarding its business operations, financial condition, and risk factors as presented in the amended report.
- Monitor future filings for any updates on legal proceedings or patent-related activities, which are critical to VirnetX's business model.
Key Dates
- 2023-12-31: Fiscal Year End — Marks the end of the reporting period for the annual report.
- 2024-04-18: Filing Date of 10-K/A — The date the amendment was officially submitted to the SEC.
Year-Over-Year Comparison
This is an amended 10-K filing for the fiscal year 2023, indicating updates or corrections to the original annual report.
Filing Stats: 2,045 words · 8 min read · ~7 pages · Grade level 8.5 · Accepted 2024-04-18 16:05:34
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share VHC NYSE Securities reg
Filing Documents
- ef20026847_10ka.htm (10-K/A) — 114KB
- ef20026847_ex10-19.htm (EX-10.19) — 20KB
- ef20026847_ex10-22.htm (EX-10.22) — 32KB
- ef20026847_ex31-3.htm (EX-31.3) — 6KB
- ef20026847_ex31-4.htm (EX-31.4) — 6KB
- ef20026847_ex97-1.htm (EX-97.1) — 40KB
- image01.jpg (GRAPHIC) — 10KB
- image02.jpg (GRAPHIC) — 3KB
- 0001140361-24-020509.txt ( ) — 470KB
- vhc-20231231.xsd (EX-101.SCH) — 4KB
- vhc-20231231_lab.xml (EX-101.LAB) — 28KB
- vhc-20231231_pre.xml (EX-101.PRE) — 21KB
- ef20026847_10ka_htm.xml (XML) — 7KB
Financial Statements: See the Index to Consolidated Financial Statements under Item 8 of the Original Annual Report
Financial Statements: See the Index to Consolidated Financial Statements under Item 8 of the Original Annual Report. (2) Financial Statement Schedule: Financial statement schedules are omitted because they are not applicable, or the required information is shown in the financial statements or notes thereto. All other schedules are omitted because of the absence of conditions under which they are required or because the required information is given in the financial statements or the notes thereto. (3) Exhibits: The documents listed in the Exhibit Index of this Amendment No. 1 to the Annual Report on Form 10-K/A are incorporated by reference or are filed with this Amendment No. 1 to the Annual Report on Form 10-K/A, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K). EXHIBIT INDEX Exhibit Number Description Incorporated by reference herein Form Exhibit No. Filing Date File No. Filed Herewith 3.1 Amended and Restated Certificate of Incorporation of the Company, as amended . 8-K 3.1 11/01/2007 000-26895 3.2 Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company . 8-K 3.1 10/25/2023 001-33852 3.3 Amended and Restated Bylaws of the Company . 8-K 3.1 1/27/2023 001-33852 4.2 Specimen Common Stock Certificate . S-3 4.1 07/30/2018 333-226413 4.3 Form of Senior Indenture . S-3 4.2 07/30/2018 333-226413 4.4 Form of Subordinated Indenture . S-3 4.4 07/30/2018 333-226413 4.5
Description of Capital Stock
Description of Capital Stock . 10-K 4.6 03/16/2020 001-33852 10.1 Form of Indemnification Agreement . 10-K 10.1 03/18/2019 001-33852 10.2* 2007 Stock Plan, as amended . 10-Q 10.2 05/10/2012 001-33852 10.3* Amended Form of Stock Option Agreement – 2007 Stock Plan . 10-Q 4.5 05/10/2011 001-33852 10.4* Form of Restricted Stock Unit Award Agreement – 2007 Stock Plan . 10-Q 10.3 05/10/2012 001-33852 10.5* 2013 Equity Incentive Plan, as amended . DEF 14A Appendix A 04/13/2021 001-33852 10.6* Amended and Restated 2013 Equity Incentive Plan . S-8 10.1 06/15/2023 333-272677 10.7* Form of Stock Option Agreement – 2013 Equity Incentive Plan and Amended and Restated 2013 Equity Incentive Plan . 10-K 10.6 03/02/2015 001-33852 10.8* Form of Restricted Stock Unit Agreement – 2013 Equity Incentive Plan and Amended and Restated 2013 Equity Incentive Plan . 10-K 10.7 03/02/2015 001-33852 10.9* Form of Restricted Stock Agreement – Amended and Restated 2013 Equity Incentive Plan . 10-Q 10.2 08/11/2023 001-33852 10.10 Patent License and Assignment Agreement by and between the Company and Leidos, Inc. (formerly Science Applications International Corporation) dated as of August 12, 2005 . 8-K 10.4 07/12/2007 000-26895 10.11** Amendment No. 1 to Patent License and Assignment Agreement by and between the Company and Leidos, Inc. dated as of November 2, 2006 . 8-K 10.6 07/12/2007 000-26895 10.12 Amendment No. 2 to Patent License and Assignment Agreement by and between VirnetX, Inc. and Leidos, Inc. dated as of March 12, 2008 . 8-K 10.1 03/18/2008 001-33852 10.13 Security Agreement by and between the Company and Leidos, Inc. dated as of August 12, 2005 . 8-K 10.5 07/12/2007 000-26895 10.14 Assignment Agreement between the Company and Leidos, Inc. dated as of December 21, 2006 . 8-K 10.7 07/12/2007 000-26895 10.15 Professional Services Agreement by and between the Company and Leidos, Inc. d
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized. VirnetX Holding Corporation By: /s/ Kendall Larsen Name: Kendall Larsen Title: Chief Executive Officer and President Dated: April 18, 2024